DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing): A phase III trial—ECOG-ACRIN EA6134.

Journal of Clinical Oncology, Volume 39, Issue 36_suppl, Page 356154-356154, December 2021.